CNBC Television Coronavirus breeds odd alliances in effort to beat pandemic

🎯 Загружено автоматически через бота: 🚫 Оригинал видео: 📺 Данное видео принадлежит каналу «CNBC Television» (@CNBCtelevision). Оно представлено в нашем сообществе исключительно в информационных, научных, образовательных или культурных целях. Наше сообщество не утверждает никаких прав на данное видео. Пожалуйста, поддержите автора, посетив его оригинальный канал. ✉️ Если у вас есть претензии к авторским правам на данное видео, пожалуйста, свяжитесь с нами по почте support@, и мы немедленно удалим его. 📃 Оригинальное описание: CNBC’s Meg Tirrell reports on unusual alliances being formed to combat the coronavirus pandemic. Johnson & Johnson is aiming to produce between 600 million and 900 million doses of its potential coronavirus vaccine by the end of the first quarter of 2021 if human trials scheduled to begin in September go as planned. It plans to make 1 billion doses or more annually, J&J executives told investors during a post-earnings conference call on Tuesday. The comments came shortly after the drugmaker raised its quarterly dividend and reported first-quarter financial results that beat Wall Street’s expectations. The company also lowered its 2020 adjusted earnings forecast due to the coronavirus outbreak. It’s now expecting a range of $ to $ per share, from its prior estimate of $ to $ per share. Late last month, the company said human testing of its experimental vaccine for the coronavirus will begin by September and could be available for emergency use authorization in early 2021. J&J also committed more than $1 billion of investment in partnership with the federal Biomedical Advanced Research and Development Authority, which is part of the Department of Health and Human Services, to co-fund vaccine research. On Tuesday, J&J CEO Alex Gorsky reiterated to investors that the U.S. drugmaker would provide the vaccine on a “not-for-profit” basis for emergency use. For more coronavirus live updates: For access to live and exclusive video from CNBC subscribe to CNBC PRO: » Subscribe to CNBC TV: » Subscribe to CNBC: » Subscribe to CNBC Classic: Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: Follow CNBC on LinkedIn: Follow CNBC News on Facebook: Follow CNBC News on Twitter: Follow CNBC News on Instagram: #CNBC #CNBC TV